RAC 2.92% $1.94 race oncology ltd

Oncology - Pharma Deals News, page-156

  1. 2,460 Posts.
    lightbulb Created with Sketch. 354
    This would be a great outcome if it happened. Totally agree with your thinking. While I want to see a large buyout, I'm quite vested in watching bisantrene getting back into clinicians hands and being administered to those of need. A friend of mine had a brain tumour when he was about 14, and I remember him speaking to me at the time about what chemo feels like and all the medication he was, and I expect is still on... Sounded so painful and life quality diminishing.
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.